Abstract: The invention encompasses methods and compositions for inducing an immune response in an anti-Gal synthesizing animal including viral and tumor antigens manipulated to express &agr;-galactosyl epitopes.
Type:
Grant
Filed:
October 15, 1998
Date of Patent:
March 26, 2002
Assignees:
Medical College of Pennsylvania, Hahnemann University
Abstract: The invention encompasses methods and compositions for inducing an immune response in an anti-Gal synthesizing animal including viral and tumor antigens manipulated to express .alpha.-galactosyl epitopes.
Type:
Grant
Filed:
September 11, 1996
Date of Patent:
March 9, 1999
Assignee:
Medical College of Pennsylvania and Hahnemann University
Abstract: The NER receptor is a novel member of the steroid hormone receptor superfamily and has been prepared by cDNA cloning from a human osteosarcoma SAOS-2/B10 cell library. The complete sequence of human NER complementary DNA (Seq. ID No. 1), expression systems including a COS stable expression system, the expressed protein (SEQ. ID No. 2) and an assay using the COS expression system are disclosed. The assay may be used to identify agents which activate transcription mediated by the NER receptor, and which are useful for potentiating the activity of a modulator of a G-protein coupled receptor wherein the G-protein coupled receptor is a member of the steroid hormone receptor superfamily.
Type:
Grant
Filed:
October 27, 1994
Date of Patent:
October 21, 1997
Assignees:
Merck & Co., Inc., Medical College of Pennsylvania, Hahnemann Univ.
Inventors:
Eitan Friedman, M. Katharine Holloway, Gideon A. Rodan, Su Jane Rutledge, Azriel Schmidt, Robert L. Vogel
Abstract: Methods of use of compounds and compositions comprising fragments and synthetic analogs of human thrombospondin are provided for promoting or inhibiting thrombospondin-like activity.
Type:
Grant
Filed:
June 1, 1995
Date of Patent:
August 5, 1997
Assignees:
W. R. Grace & Co.-Conn., The Medical College of Pennsylvania
Inventors:
Jacob Eyal, Bruce King Hamilton, George Paul Tuszynski
Abstract: Compounds and compositions comprising fragments and synthetic analogs of human thrombospondin are provided together with methods for their use as thrombospondin-like agents.
Type:
Grant
Filed:
June 7, 1995
Date of Patent:
July 15, 1997
Assignees:
W.R. Grace & Co.-Conn, The Medical College of Pennsylvania
Inventors:
Jacob Eval, Bruce King Hamilton, George Paul Tuszynski
Abstract: Methods of use of compounds and compositions comprising fragments and synthetic analogs of human thrombospondin are provided for promoting or inhibiting thrombospondin-like activity.
Type:
Grant
Filed:
March 22, 1995
Date of Patent:
April 9, 1996
Assignees:
W. R. Grace & Co.-Conn., The Medical College of Pennsylvania
Inventors:
Jacob Eyal, Bruce K. Hamilton, George P. Tuszynski
Abstract: A method of treatment of Cryptococcus neoformans infection by administering to a patient in need thereof an effective amount of a benzimidazile compound.
Abstract: A cyto(histo)chemical technique for determining inosine 5'-monophosphate dehydrogenase (IMPD) presence and concentration within one or more morphologically classified or classifiable cells taken from an animal or a human subject. Cell monolayers are prepared, fixed and stained according to a specified procedure in which inosine 5'-monophosphate (as enzyme substrate), nicotinamide adenine dinucleotide (NAD), phenazine methosulfate (PMS) and nitro blue tetrazolium (NBT) as a diazonium salt together produce a granular, dark blue deposit of formazan generally proportional to the IMPD activity in the cell. Cells are evaluated either visually or by image analysis, with a computerized image analyzer or other imaging system, according to accepted biostatistical methods and standards.
Type:
Grant
Filed:
May 14, 1992
Date of Patent:
October 25, 1994
Assignee:
The Medical College of Pennsylvania
Inventors:
Olivera T. Markovic, Nenad S. Markovic, Jay Roberts, Charles D. Puglia, Svetomir N. Markovic
Abstract: Compounds and compositions comprising fragments and synthetic analogs of human thrombospondin are provided together with methods for their use as thrombospondin-like agents.
Type:
Grant
Filed:
January 31, 1991
Date of Patent:
April 6, 1993
Assignees:
W. R. Grace & Co.-Conn., The Medical College of Pennsylvania
Abstract: Compounds and compositions comprising fragments and synthetic analogs of human thrombospondin are provided together with methods for their use as thrombospondin-like agents.
Type:
Grant
Filed:
February 22, 1990
Date of Patent:
March 2, 1993
Assignees:
W. R. Grace & Co.-Conn., The Medical College of Pennsylvania
Abstract: Pharmaceutical compositions and dressings useful in wound healing are provided. The pharmaceutical compositions comprise thrombospondin as the active ingredient.
Type:
Grant
Filed:
February 22, 1990
Date of Patent:
October 13, 1992
Assignees:
W. R. Grace & Co.-Conn., Medical College of Pennsylvania